Quick Heal Technologies Limited

Quick Heal Technologies Limited

Quick Heal Technologies Limited has submitted a disclosure to the NSE under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing confirms the company's adherence to regulatory requirements concerning changes in shareholding or control. Regulation 31(4) typically relates to promoters or persons in control modifying or revoking undertakings not to encumber shares. While this announcement does not detail the specifics of Quick Heal's disclosure, such submissions are crucial for maintaining transparency around potential shifts in ownership structure. Investors should monitor subsequent announcements for the full context and any implications for the company's control.

Quick Heal Technologies Limited

Quick Heal Technologies Limited has granted 220,000 employee stock options to employees under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Quick Heal Technologies Limited

Quick Heal Technologies Limited has appointed Mr. Harish Kumar GS as its Chief Executive Officer, effective June 18, 2026.

Quick Heal Technologies Limited

Quick Heal Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 18, 2026, where the Board approved the appointment of Mr. Harish Kumar GS as Chief Executive Officer and Key Managerial Personnel.